Shakiba Yadollah, Mostafaie Ali
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Arch Med Res. 2007 Oct;38(7):789-91. doi: 10.1016/j.arcmed.2007.04.006. Epub 2007 Jun 21.
Corneal neovascularization is a significant, sight-threatening complication of many ocular surface disorders. Various growth factors and proteinases are involved in corneal neovascularization. The data supporting a causal role for vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) are extensive. Inhibition of VEGF and MMPs is a main strategy for treating corneal neovascularization. Several findings have shown that corneal neovascularization can be reduced by using anti-VEGF and anti-MMPs agents. Efficacy of a nutrient mixture (NM) containing lysine, proline, ascorbic acid, and green tea extract has been demonstrated for reducing VEGF and MMPs secretion by various cells. Moreover, NM can inhibit endothelial cell migration and capillary tube formation. We herein note that topical application of NM is potentially useful for inhibiting corneal neovascularization and restoration of corneal clarity. Further investigations in animal models are needed to place NM alongside corneal neovascularization therapeutics.
角膜新生血管形成是许多眼表疾病的一种严重的、威胁视力的并发症。多种生长因子和蛋白酶参与角膜新生血管形成。支持血管内皮生长因子(VEGF)和基质金属蛋白酶(MMPs)起因果作用的数据很广泛。抑制VEGF和MMPs是治疗角膜新生血管形成的主要策略。多项研究结果表明,使用抗VEGF和抗MMPs药物可减少角膜新生血管形成。含有赖氨酸、脯氨酸、抗坏血酸和绿茶提取物的营养混合物(NM)已被证明可减少各种细胞分泌VEGF和MMPs。此外,NM可抑制内皮细胞迁移和毛细血管管腔形成。我们在此指出,局部应用NM可能有助于抑制角膜新生血管形成并恢复角膜透明度。需要在动物模型中进行进一步研究,以便将NM纳入角膜新生血管形成的治疗方法中。